Unruptured Cerebral Aneurysm with Significant Comorbid Diseases or Reduced Life Expectancy: Management Approach
When an asymptomatic unruptured intracranial aneurysm is identified in a patient whose overall health or life expectancy substantially limits the benefit horizon of intervention, the standard risk–benefit calculus for aneurysm repair shifts considerably. Evidence-based guidance addresses this population directly.
Clinical scenario
Asymptomatic unruptured intracranial aneurysm (UIA) in an adult patient with significant comorbid diseases and/or a reduced life expectancy of less than 5 years. In this setting, comorbidity burden and prognosis are central to determining whether preventive aneurysm repair is appropriate.
Management overview (partial)
Current evidence-based guidance for this patient profile includes specific recommendations on the role and appropriateness of preventive aneurysm repair — weighing procedural risk against expected benefit given the patient's comorbidity profile and projected survival. The complete structured protocol is available via the link below.
References
DOI: 10.1177/23969873221099736
In asymptomatic adult UIA patients with significant comorbid diseases and/or reduced life expectancy (<5 years), we suggest no preventive aneurysm repair.
View source ↗